These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 23613404)
1. Contribution of immunohistochemistry in the differential diagnosis of non-small cell lung carcinomas on small biopsy samples. Stojsic J; Jovanic I; Markovic J; Gajic M J BUON; 2013; 18(1):176-87. PubMed ID: 23613404 [TBL] [Abstract][Full Text] [Related]
2. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung. Argon A; Nart D; Veral A Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390 [TBL] [Abstract][Full Text] [Related]
3. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
4. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis. Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623 [TBL] [Abstract][Full Text] [Related]
5. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique. Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549 [TBL] [Abstract][Full Text] [Related]
6. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515 [TBL] [Abstract][Full Text] [Related]
7. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers. Kulshrestha R; Vijayan VK Indian J Chest Dis Allied Sci; 2009; 51(1):21-5. PubMed ID: 19317359 [TBL] [Abstract][Full Text] [Related]
9. The role of the cytopathologist in subtyping and epidermal growth factor receptor testing in non-small cell lung cancer: An institutional experience. Sekar A; Gupta N; Rajwanshi A; Chaturvedi R; Singh N; Lal A Cytopathology; 2017 Oct; 28(5):371-377. PubMed ID: 28730709 [TBL] [Abstract][Full Text] [Related]
10. If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lung. Downey P; Cummins R; Moran M; Gulmann C APMIS; 2008 Jun; 116(6):526-9. PubMed ID: 18754327 [TBL] [Abstract][Full Text] [Related]
11. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung. van Zyl A; Schubert PT; Koegelenberg CFN Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846 [TBL] [Abstract][Full Text] [Related]
12. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples. Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Rekhtman N; Ang DC; Sima CS; Travis WD; Moreira AL Mod Pathol; 2011 Oct; 24(10):1348-59. PubMed ID: 21623384 [TBL] [Abstract][Full Text] [Related]
14. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer. Owen D; Sheffield BS; Ionescu D; Churg A Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124 [TBL] [Abstract][Full Text] [Related]
15. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis. Yaman B; Nart D; Ekren PK; Çok G; Veral A Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962 [TBL] [Abstract][Full Text] [Related]
16. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614 [TBL] [Abstract][Full Text] [Related]
17. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens. Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420 [TBL] [Abstract][Full Text] [Related]
18. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Kim MJ; Shin HC; Shin KC; Ro JY Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
20. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Warth A; Muley T; Herpel E; Meister M; Herth FJ; Schirmacher P; Weichert W; Hoffmann H; Schnabel PA Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]